Loading…
Loading…
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for 4113.TWO and 80,000+ other tickers.
See exactly how 4113.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 4113.TWO and 80,000+ other tickers.
We & Win Diversification Co., Ltd., a company headquartered in Kaohsiung City, Taiwan, primarily focuses on the acquisition, rental, and sale of real estate properties across the island. Beyond its core property activities, the firm's operations encompass a diverse range of sectors, including investments in public infrastructure projects, the development of new towns and communities, the wholesale distribution of medical equipment, and various international trade endeavors. Established in 1987, the entity originally traded as Oncoprobe Biotech Inc. before adopting its current designation of We & Win Diversification Co., Ltd. in 2009.
No recent news available.